Crossmark

Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma

Published Online: 2021-06-30

Authors

Zhang, Yalu

Liu, Qiaofei

Liu, Jingkai

Liao, Quan https://orcid.org/0000-0003-1324-6213
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81872501)

National Natural Science Foundation of China (81673023)

National Natural Science Foundation of China (81272573)

National Natural Science Foundation of China (81502068)

Natural Science Foundation of Beijing Municipality (7172177)
License Information

Text and Data Mining valid from 2021-06-30

Version of Record valid from 2021-06-30
More Information

Article History

Received: 29 March 2021

Accepted: 21 June 2021

First Online: 30 June 2021

Declarations

:

: This study involved in human specimens was approved by the Ethics Committee of Peking Union Medical College Hospital.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current